Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Samen recombinant human growth hormone versus NOVO growth hormone in children with growth hormone deficiency
IRCT1138901181414N11Phase 3Completed
- Sponsor
- Samen Pharmaceutical
- Start
- Aug 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of somatropin in growth hormone deficiency (GHD) (2 arms), sponsored by Samen Pharmaceutical. Started Aug 2006; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on IRCT1138901181414N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT1138901181414N11.